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In the title compound, C21H24O3, the conformation of the
enone group is s–cis. The benzene rings are inclined at an
angle of 7.9 (1). The alkoxy tail is planar, with a maximum
deviation from the least-squares plane of 0.009 (2) Å, and
adopts a trans conformation throughout. An intramolecular
O—H  O interaction between the keto and hydroxy groups
forms S(6) ring motifs. In the crystal, molecules are arranged
in a head-to-tail manner down the a axis and are subsequently
stacked along the b axis, forming molecular sheets parallel to
the ab plane. The crystal structure is further stabilized by weak
C—H   interactions and short C  O [3.376 (2) Å] contacts.
Related literature
For the biological properties of chalcone derivatives, see: Bhat
et al. (2005); Xue et al. (2004); Zhao et al. (2005); Lee et al.
(2006). For related structures, see: Razak, Fun, Ngaini,
Rahman & Hussain (2009); Razak, Fun, Ngaini, Fadzillah &
Hussain (2009a,b); Ngaini, Fadzillah et al. (2009); Ngaini,
Rahman et al. (2009). For details of hydrogen-bond motifs, see:
Bernstein et al. (1995). For the stability of the temperature







a = 19.6443 (5) Å
b = 7.1966 (2) Å
c = 12.6520 (3) Å
 = 106.438 (2)
V = 1715.53 (8) Å3
Z = 4
Mo K radiation
 = 0.08 mm1
T = 100 K
0.47  0.12  0.04 mm
Data collection




Tmin = 0.962, Tmax = 0.997
20873 measured reflections
5025 independent reflections
2783 reflections with I > 2(I)
Rint = 0.057
Refinement
R[F 2 > 2(F 2)] = 0.070




H atoms treated by a mixture of
independent and constrained
refinement
max = 0.53 e Å
3
min = 0.29 e Å
3
Table 1
Hydrogen-bond geometry (Å, ).
D—H  A D—H H  A D  A D—H  A
O1—H1O1  O2 0.90 (3) 1.68 (3) 2.507 (2) 152 (2)
C20—H20A  Cg1i 0.97 2.84 3.657 (2) 142
C20—H20B  Cg1ii 0.97 2.78 3.637 (2) 147
Symmetry codes: (i) x; y 12;zþ
1




2. Cg1 is the centroid of the
C1-C6 ring.
Data collection: APEX2 (Bruker, 2005); cell refinement: SAINT
(Bruker, 2005); data reduction: SAINT; program(s) used to solve
structure: SHELXTL (Sheldrick, 2008); program(s) used to refine
structure: SHELXTL; molecular graphics: SHELXTL; software used
to prepare material for publication: SHELXTL and PLATON (Spek,
2009).
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